KOPS - Das Institutionelle Repositorium der Universität Konstanz

CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-α release from lipopolysaccharide-treated cells and mice

CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-α release from lipopolysaccharide-treated cells and mice

Zitieren

Dateien zu dieser Ressource

Prüfsumme: MD5:72f5b39a2a6b9d1b9c4483c689ed7fae

CIALLELLA, John R., Michael SAPORITO, Søren LUND, Marcel LEIST, Henrik HASSELDAM, Natalie MCGANN, Charles S. SMITH, Donna BOZYCZKO-COYNE, Dorothy G. FLOOD, 2005. CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-α release from lipopolysaccharide-treated cells and mice. In: European Journal of Pharmacology. 515(1-3), pp. 179-187. ISSN 0014-2999. eISSN 1879-0712. Available under: doi: 10.1016/j.ejphar.2005.04.016

@article{Ciallella2005-05-16CEP11-40816, title={CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-α release from lipopolysaccharide-treated cells and mice}, year={2005}, doi={10.1016/j.ejphar.2005.04.016}, number={1-3}, volume={515}, issn={0014-2999}, journal={European Journal of Pharmacology}, pages={179--187}, author={Ciallella, John R. and Saporito, Michael and Lund, Søren and Leist, Marcel and Hasseldam, Henrik and McGann, Natalie and Smith, Charles S. and Bozyczko-Coyne, Donna and Flood, Dorothy G.} }

<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/40816"> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dcterms:title>CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-α release from lipopolysaccharide-treated cells and mice</dcterms:title> <dcterms:issued>2005-05-16</dcterms:issued> <dc:creator>Flood, Dorothy G.</dc:creator> <dc:rights>terms-of-use</dc:rights> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/40816"/> <dc:contributor>Ciallella, John R.</dc:contributor> <dc:contributor>Smith, Charles S.</dc:contributor> <dc:contributor>Flood, Dorothy G.</dc:contributor> <dc:contributor>Hasseldam, Henrik</dc:contributor> <dc:contributor>Saporito, Michael</dc:contributor> <dc:creator>Hasseldam, Henrik</dc:creator> <dc:contributor>McGann, Natalie</dc:contributor> <dc:contributor>Lund, Søren</dc:contributor> <dc:creator>McGann, Natalie</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-12-01T09:41:56Z</dc:date> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:language>eng</dc:language> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/40816/1/Ciallella_2-1kj497g7ftj4z1.pdf"/> <dc:creator>Ciallella, John R.</dc:creator> <dc:creator>Lund, Søren</dc:creator> <dc:creator>Saporito, Michael</dc:creator> <dc:creator>Leist, Marcel</dc:creator> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/40816/1/Ciallella_2-1kj497g7ftj4z1.pdf"/> <dc:creator>Bozyczko-Coyne, Donna</dc:creator> <dc:contributor>Leist, Marcel</dc:contributor> <dcterms:abstract>CEP-11004, a mixed lineage kinase (MLK) inhibitor, was examined for its effects on tumor necrosis factor-alpha (TNF-α) production in human THP-1 monocytes, mouse BV-2 microglia, and C57Bl/6 mice. CEP-11004 inhibited TNF-α secretion up to 90% in THP-1 cells incubated with 3 μg/ml lipopolysaccharide, with an IC50 of 137 ± 14 nM. CEP-11004 also inhibited TNF-α production in lipopolysaccharide-stimulated microglial cells, but did not inhibit the initial increase in TNF-α mRNA expression as measured by real-time polymerase chain reaction (PCR). The mitogen-activated protein kinases (MAPKs) phospho-c-jun N-terminal kinase (JNK), phospho-p38, and phospho-MAPK kinase 4 (MKK4) levels were increased in THP-1 cells following lipopolysaccharide treatment, and were reduced by CEP-11004 treatment. For in vivo studies, CEP-11004 was injected 2 h prior to lipopolysaccharide (20 mg/kg) administration. CEP-11004 significantly inhibited TNF-α production at doses of 1–10 mg/kg as measured by enzyme-linked immunosorbent assay (ELISA). These results suggest that MLK blockade may be useful in inhibiting pro-inflammatory cytokine production in a wide range of diseases.</dcterms:abstract> <dc:creator>Smith, Charles S.</dc:creator> <dc:contributor>Bozyczko-Coyne, Donna</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-12-01T09:41:56Z</dcterms:available> <dcterms:rights rdf:resource="https://kops.uni-konstanz.de/page/termsofuse"/> </rdf:Description> </rdf:RDF>

Dateiabrufe seit 01.12.2017 (Informationen über die Zugriffsstatistik)

Ciallella_2-1kj497g7ftj4z1.pdf 36

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto